2015 No. 130
The Health Services (Cross-Border Health Care) (Amendment) Regulations (Northern Ireland) 2015
Made
Coming into operation
The Department of Health, Social Services and Public Safety1, makes the following Regulations in exercise of the powers conferred by section 2(2) of the European Communities Act 19722.
The Department of Health, Social Services and Public Safety is a Department designated for the purposes of section 2(2) of the European Communities Act 1972 in relation to cross-border health care3.
Citation and commencementI11
These Regulations may be cited as The Health Services (Cross-Border Health Care) (Amendment) Regulations (Northern Ireland) 2015 and shall come into operation on 27th March 2015.
Amendments to the Health Services (Cross-Border Health Care) Regulations (Northern Ireland) 2013I22
1
The Health Services (Cross-Border Health Care) Regulations (Northern Ireland) 20134 are amended as follows.
2
After regulation 5 (National Contact Point: Information about treatment in another member State) insert—
National Contact Point: information about prescriptions intended to be used in another member State5A
1
The NCP must make available to patients information about the elements, specified in the Schedule, to be included in a prescription which is—
a
issued in one member State, and
b
intended to be used in another member State.
3
Add the following Schedule—
SCHEDULEElements that must be included in prescriptions intended to be used in another member State
1
The patient’s—
a
surname,
b
first names, and
c
date of birth.
2
The issue date of the prescription.
3
The prescribing professional’s—
a
surname,
b
first names,
c
professional qualification,
d
direct contact details including—
i
email address, and
ii
telephone or fax number with the appropriate international prefix,
e
work address,
f
member State in which the professional works,
g
signature (either written in ink or electronic depending on the medium chosen for issuing the prescription).
4
The details of the prescribed product, including where applicable the—
a
common name as defined by Article 1 of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (“Directive 2001/83/EC”)5,
b
brand name if—
i
the prescribed product is a biological medicinal product, as defined in point 3.2.1.1(b) of Annex 1 (Part 1) to Directive 2001/83/EC, or
ii
the prescribing professional deems it medically necessary for that product to be dispensed and, in that case, the prescribing professional’s reasons justifying the use of the brand name,
c
pharmaceutical formulation (such as tablet, solution etc),
d
quantity,
e
strength, as defined in Article 1 of Directive 2001/83/EC, and
f
dosage regimen.
Sealed with the Official Seal of the Department of Health, Social Services and Public Safety on 6th March 2015
(This note is not part of the Regulations)